The number of winners is a historic low for the Island but still higher than any other region in the United States.

Among other things, we talked about President Trump’s “most-favored nations” policy on drug pricing and why Regeneron is the ...

The company will prioritise investment for in-house innovation over large M&A deals, bucking the trend across pharma.

Could the tide be turning for Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) after a surprising shift in analyst sentiment?

During a live event, Omid Hamid, MD, discussed the logistics and multidisciplinary process of using tumor-infiltrating ...

Regeneron Pharmaceuticals (NASDAQ: REGN) underwent analysis by 21 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

More than half a dozen major drugmakers are participating in the Trump administration's speedier review program for new ...

President Donald Trump on Thursday announced the outlines of a health care plan he wants Congress to take up as Republicans ...

The vaccines subsector received a big fillip from Covid, but its potential extends far beyond combating pandemics. Dr Mike ...

Sanofi (SAN:CA) 44th Annual J.P. Morgan Healthcare Conference January 12, 2026 12:45 PM ESTCompany ParticipantsPaul Hudson - CEO & ...